References
Original article
Tiacci, E. et al. Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia. N. Engl. J. Med. 384, 1810–1823 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. HCL — vemurafenib plus rituximab holds promise. Nat Rev Clin Oncol 18, 399 (2021). https://doi.org/10.1038/s41571-021-00526-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00526-9
- Springer Nature Limited